Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02056873 · ClinicalTrials.gov registry record · NA
Tourette Syndrome Deep Brain Stimulation
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT02056873 is a NA study that has completed, run by University of Florida. The registered enrollment target is 10 participants.
The verdict
NCT02056873, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effectiveness and safety of deep brain stimulation (DBS) as a possible new treatment for Tourette Syndrome (TS). This investigation will (1) test the hypothesis that centromedian (CM) continuous brain stimulation will be an effective, safe method for the treatment of tics in medication refractory TS, (2) will define the intra-operative and post-operative physiological changes, and (3) will test the hypothesis that responsive brain stimulation (RBS) will provide an alternative to chronic DBS in TS.
Interventions
- DEVICE Continuous DBS
- DEVICE Responsive Brain Stimulation (RBS Setting)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2014-03-20 |
| Est. Completion | 2023-08-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02056873
The ClinicalTrials.gov registry entry for NCT02056873 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Continuous DBS is the first listed.
NCT02056873 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02056873 about?
NCT02056873 is a clinical study titled "Tourette Syndrome Deep Brain Stimulation". The purpose of this study is to evaluate the effectiveness and safety of deep brain stimulation (DBS) as a possible new treatment for Tourette Syndrome (TS). This investigation will (1) test the hypothesis that centromedian (CM) continuous brain stimulation will be an effective, safe method for the...
What is the current status of trial NCT02056873?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2014-03-20. Estimated completion is 2023-08-24.
What interventions are being tested in trial NCT02056873?
The interventions under investigation include: Continuous DBS (DEVICE), Responsive Brain Stimulation (RBS Setting) (DEVICE).
Who is sponsoring clinical trial NCT02056873?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.